Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />MALVERN, Pa., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar<sup>®</sup> TMS technology and direct patient care through the Greenbrook network of...
Full story
Read the full story at Business Insider ↗
Continue reading this story on Business Insider, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.